MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9

[1] Blobel CP(2005)ADAMs: key components in EGFR signalling and development Nat Rev Mol Cell Biol 6 32-43

[2] Cairns P(1998)Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers Oncogene 16 3215-3218

[3] Evron E(1991)Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma Oncogene 6 2305-2309

[4] Okami K(2005)Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype Clin Cancer Res 11 5740-5747

[5] Halachmi N(2013)Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma Clin Exp Metastasis 30 651-658

[6] Esteller M(2012)Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer Urol Oncol 30 434-443

[7] Herman JG(2010)miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer Br J Cancer 102 883-891

[8] Bose S(2008)Molecular alterations associated with bladder cancer initiation and progression Scand J Urol Nephrol Suppl 218 154-165

[9] Wang SI(2009)Role of ADAMs in cancer formation and progression Clin Cancer Res 15 1140-1144

[10] Parsons R(2006)Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 259-269

[1] Blobel CP(2005)ADAMs: key components in EGFR signalling and development Nat Rev Mol Cell Biol 6 32-43

[2] Cairns P(1998)Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers Oncogene 16 3215-3218

[3] Evron E(1991)Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma Oncogene 6 2305-2309

[4] Okami K(2005)Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype Clin Cancer Res 11 5740-5747

[5] Halachmi N(2013)Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma Clin Exp Metastasis 30 651-658

[6] Esteller M(2012)Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer Urol Oncol 30 434-443

[7] Herman JG(2010)miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer Br J Cancer 102 883-891

[8] Bose S(2008)Molecular alterations associated with bladder cancer initiation and progression Scand J Urol Nephrol Suppl 218 154-165

[9] Wang SI(2009)Role of ADAMs in cancer formation and progression Clin Cancer Res 15 1140-1144

[10] Parsons R(2006)Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 259-269